Discover
Stocks
Consumer Goods
ITCI
ITCI
Intra-Cellular Therapies Inc
50.06
0.32
(
0.64%
)
Market Closed
Delayed Prices By NASDAQ,
in USD
Trade
Buy
ITCI
Intra-Cellular Therapies Inc
Overview
Chart
Analysis
News
Stats
Trade
Buy
FINANCIAL SUMMARY
For the fiscal year ended 31/12/2022: Intra-Cellular Therapies Inc's revenues increased by 198.69% and amounted to 250.31M. Net income increased by 9.81% to -256.26M. Net assets increased by 57.00% to 656.07M and EPS increased from -3.50 to -2.72.
ITCI's Investor Relations
Income Statement
Balance Sheet
Cash Flow Statement
Quarterly
Gross Margin
92.74%
Net Profit Margin
-49,030.03%
Operating Margin
-54.29%
Return On Investment
-50.83%